Zonisep 50 Capsule

Zonisep 50 is typically used as adjunctive therapy in patients with refractory partial seizures who have not achieved adequate control with other antiepileptic drugs. The capsule formulation allows for convenient oral administration with good bioavailability. Dosage should be individualized based on clinical response and tolerability, with gradual titration recommended to minimize adverse effects.

Common side effects may include dizziness, somnolence, headache, and gastrointestinal disturbances. Rare but serious adverse reactions such as metabolic acidosis, hypersensitivity, and renal calculi have been reported, necessitating regular monitoring of renal function and metabolic parameters during therapy. Zonisep 50 should be used cautiously in patients with sulfonamide allergy, hepatic or renal impairment, and in pregnant or breastfeeding women unless the potential benefits outweigh risks.

Concomitant use with other central nervous system depressants may potentiate sedation. Overall, Zonisep 50 Capsule is a valuable option in the comprehensive management of partial epilepsy.